Grants.govNational Institutes of Health

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Posted Nov 6, 2024·open

AGENCY

HHS-NIH11

PROGRAM

Discretionary

AMOUNT

Up to $500K

CLOSES

Jan 7, 2028

Apply on Grants.gov ↗More info from funder ↗

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

Eligibility

Small businesses; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); County governments; Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments); Special district governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; For profit organizations other than small businesses; Independent school districts; Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; Private institutions of higher education

Contact

National Institutes of Health

grantsinfo@nih.gov

301-402-2541

Additional details

Funding instrument: Grant
Cost sharing required: No
Archived: Feb 12, 2028

Opportunity number: PAR-25-175

Search this number on Grants.gov for the official listing.